A 26-year-old male with a 10-year history of untreated cryptogenic intermittent claudication and toe necrosis presented after a recent acute myocardial infarction that required left anterior descending artery stenting. He was referred to our hospital for the diagnosis and treatment of unexplained premature peripheral artery disease (PAD), left ventricular (LV) dysfunction (LV ejection fraction 23%, diffuse hypokinesis), and juvenile hypertension. An enhanced computed tomography confirmed severe PAD with extensive long segment occlusions of the infrarenal abdominal aorta, bilateral iliac and femoral arteries as well as bilateral renal artery stenosis (Panel A). Aortic magnetic resonance imaging (MRI) demonstrated late gadolinium enhancement (LGE) of the circumferential wall in the descending aorta (Panel B) and occlusive abdominal aorta. F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) displayed diffuse FDG uptake in the LV wall (Panel C). These findings suggested a diffuse inflammatory disorder affecting both large and medium sized arteries as
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